Most Read

Quantum Computing and Drug Development

The Ideology of Right and Left: Between Radicalism and Liberalism

Saudi Electricity Company Reports 18% Revenue Growth, Reaching 88.7 Billion in 2024, with Record-High Capital Investments of 60 Billion

Saudi Arabia: Diplomatic excellence inspiring global confidence
PIF signs $15 billion revolving credit facility
الأربعاء - 28 أغسطس 2024
Wed - 28 Aug 2024
PIF has obtained a $15 billion revolving credit facility for general corporate purposes.
This replaces the previous $15 billion revolving credit facilityagreed in 2021.
This $15 billion revolving credit facility is offered for an initial period of three years, and is extendable for up to two additional years.
The facility agreement was signed with a diverse global syndicate of 23 financial institutions from Europe, the U.S., the Middle East and Asia.
The financing reflects PIF's strong credit rating as well as robust demand from PIF’s relationship banks and financial institutions.
Signing this facility represents a continuation of PIF’s strategy of using a diverse range of financing instruments.
Loans and debt instruments represent one of PIF’s four sources of funding.
The other three are capital injections from government, government assets transferred to PIF and retained earnings from investments.
PIF is currently rated A1 by Moody’s with a positive outlook and A+ by Fitch with a stable outlook.
Related Articles

صندوق الاستثمارات العامة يوقع اتفاقية تسهيلات ائتمانية دوارة بقيمة 15 مليار دولارصندوق الاستثمارات العامة يوقع اتفاقية تسهيلات ائتمانية دوارة بقيمة 15 مليار دولار

صندوق الاستثمارات العامة يوقع اتفاقية تسهيلات ائتمانية دوارة بقيمة 15 مليار دولارصندوق الاستثمارات العامة يوقع اتفاقية تسهيلات ائتمانية دوارة بقيمة 15 مليار دولار

Saudi Electricity Company Reports 18% Revenue Growth, Reaching 88.7 Billion in 2024, with Record-High Capital Investments of 60 BillionSaudi Electricity Company Reports 18% Revenue Growth, Reaching 88.7 Billion in 2024, with Record-High Capital Investments of 60 Billion

Quantum Computing and Drug DevelopmentQuantum Computing and Drug Development